ANI Pharmaceuticals, Inc.
ANIP
$75.42
-$1.12-1.46%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 522.94% | 672.15% | -137.80% | -159.21% | -198.63% |
| Total Depreciation and Amortization | 34.97% | 51.52% | 41.38% | 27.03% | 13.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.08% | 30.27% | 231.32% | 525.94% | 67.38% |
| Change in Net Operating Assets | 36.32% | -30.14% | 120.62% | -97.75% | -144.99% |
| Cash from Operations | 189.34% | 83.77% | 23.58% | -30.28% | -46.19% |
| Capital Expenditure | 14.79% | 7.05% | -4.95% | -27.29% | -83.09% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | -100.00% | -- |
| Cash Acquisitions | -- | 97.91% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,757.18% | -551.96% | -294.88% | -87.66% | 92.56% |
| Cash from Investing | 91.52% | 89.07% | -8,892.53% | -5,899.97% | -2,086.37% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | 96.57% | 97.24% | -9,853.10% | -9,810.40% | -9,767.70% |
| Issuance of Common Stock | 109.68% | 125.93% | -40.18% | -93.01% | -92.75% |
| Repurchase of Common Stock | -11.41% | -9.60% | -6.35% | -21.80% | -119.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 28.80% | 3.82% | 0.00% | 0.00% | 0.00% |
| Other Financing Activities | 99.96% | 95.32% | -146.71% | -146.71% | -493.42% |
| Cash from Financing | -103.75% | -103.96% | 1,035.45% | 425.76% | 292.87% |
| Foreign Exchange rate Adjustments | 50.43% | 1,066.67% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 284.62% | 344.75% | -128.41% | -148.97% | -145.40% |